EpiMonitor

Next-Gen Epilepsy Monitoring

Available in the US, UK, EU, AU, NZ and CA

Embrace2

Embrace2

Peace of Mind

No longer available for purchase

Empatica Logo
  • Solutions

    Empatica Health Monitoring Platform

    Empatica Health Monitoring Platform

    One platform, multiple applications

    Components

    EmbracePlus wearable
    EmbraceMini wearable
    New
    Care software suite
    eCOA
    Digital biomarkers
    Cloud API for Clinical Trials

    Use Cases

    Clinical Trials
    Designed for the patient, enhanced for the scientist
    Actigraphy
    The new standard to measure sleep and physical activity
    Contract Research Organizations
    Enhanced value and effortless integrations for CROs
    Parkinson's Monitoring
    New
    Improve patient outcomes with validated PKG measures
    Parkinson’s & Movement Disorders
    Digital endpoints for Parkinson's and movement disorders trials
    Academic Research
    Unlock the future of real-world research
    Go to store
  • Scientific Evidence

    Publications
    Scientific publications using our technology
    Case Studies
    Client success stories
  • Resources

    Compliance
    Global regulatory requirements
    Blog
    Thoughts and news
    Digital resources library
    Online and downloadable resources
    Support center
    Get support with our products
  • Company

    About us
    People with purpose
    Careers
    Join the mission
    Contact us
    Talk to our team
Contact Us
Empatica Logo
Empatica Health Monitoring Platform

Empatica Health Monitoring Platform

One platform, multiple applications

Components

EmbracePlus wearable
EmbraceMini wearable
New
Care software suite
eCOA
Digital biomarkers
Cloud API for Clinical Trials

Use Cases

Clinical Trials
Designed for the patient, enhanced for the scientist
Actigraphy
The new standard to measure sleep and physical activity
Contract Research Organizations
Enhanced value and effortless integrations for CROs
Parkinson's Monitoring
New
Improve patient outcomes with validated PKG measures
Parkinson’s & Movement Disorders
Digital endpoints for Parkinson's and movement disorders trials
Academic Research
Unlock the future of real-world research
Go to store
Publications
Scientific publications using our technology
Case Studies
Client success stories
Compliance
Global regulatory requirements
Blog
Thoughts and news
Digital resources library
Online and downloadable resources
Support center
Get support with our products
About us
People with purpose
Careers
Join the mission
Contact us
Talk to our team
EpiMonitor

Next-Gen Epilepsy Monitoring

Available in the US, UK, EU, AU, NZ and CA

Embrace2
Embrace2

Peace of Mind

No longer available for purchase

Contact Us
Product

How wearables and AI can help in the battle against COVID-19

Empatica

Empatica

Mar 24, 2021• 4 min read

LinkedinFacebookX

In recent years, wearables have grown in popularity. As the number of health-conscious people also grows, the demand for tech that can actively monitor one’s health increases as well. But aside from helping you to stay on top of your health or sending notifications, studies have shown that wearable tech combined with artificial intelligence (AI) can be used to detect COVID-19 infections in people even before they start showing symptoms.

In a study published by Stanford University, experts were able to precisely identify two out of every three people infected with COVID-19 at least four days before they experienced symptoms. They were able to do this by using deviations in people’s resting heart rate. Similar findings were published by Scripps College, which used wearable data information such as heart rate, temperature, sleep, and activity levels. Researchers were able to predict COVID-19 with at least 80% accuracy — a remarkably better result compared to solely tracking people's symptoms.

In a pandemic, early detection is key. And this is one of the goals of developing wearable technology. By alerting the user that their biological data information points to early signs of infection, they can quickly isolate themselves and get a confirmatory test. Frank J. Penedo, professor at the Miller School of Medicine's psychology and medicine programs, explains how wearable tech can be used for early detection: "When you put it all together, you have a pretty comprehensive set of biological data that can give you a picture of how the individual is functioning prior to developing overt symptoms of disease.”

Nonetheless, wearable tech is a promising tool to help us overcome the pandemic. Empatica’s EmbracePlus, a medical device designed elegantly to look like a consumer smartwatch, features clinical-grade sensors which can help measure pulse rate, pulse rate variability, respiratory rate, electrodermal activity, and temperature. Through monitoring your vital signs around-the-clock, the EmbracePlus can also check for patterns that signify COVID-19 infection and notify you via a dedicated app. This, then, encourages you to self-isolate until you get the results of your COVID-19 test.

This can be done via the Empatica Aria algorithm, able to provide you with a daily risk. In addition, Aria can also be used to track patients or protect private institutions. Stringent screening and monitoring efforts have made it possible to further prevent COVID-19 from spreading. And through wearable tech and tracking platforms, it is far easier to monitor people and their condition. Despite the ongoing vaccine rollout, wearable technology can still be of great use in detecting early signs of COVID-19, especially for places with low vaccine confidence and slow vaccine procurement or distribution. In addition, this can aid us in the battle against COVID-19, and further development of this tech can prepare us for any similar viruses we might face in the future.

Specially written for empatica.com by Reese Jones.

The Aria system can be used by anyone aged 14 and up, and is now available across Europe for healthcare providers and other professionals who seek to contain the spread of infectious diseases within their communities. Contact sales@empatica.com or reach out to our team through this quick form to request more info.

We do not guarantee that EpiMonitor will detect every single seizure and deliver alerts accordingly. It is not meant to substitute your current seizure monitoring practices, but rather to serve as a supplement in expediting first-response time.

Company
About us
Careers
Legal
Blog
Empatica Health Monitoring Platform
Clinical Trials
Academic Research
Actigraphy
Parkinson's Monitoring
Parkinson’s & Movement Disorders
Log in
Care Portal
Care Lab Portal
Research Portal
Epilepsy Monitoring
EpiMonitor
Embrace2
Get Support
Contact Us
Manuals
Empatica
FacebookInstagramYouTubeTwitterLinkedin

Empatica Inc., 1 Broadway, 14th floor, Cambridge MA 02142 United States - Empatica Srl, Via Stendhal 36, 20144 Milano (MI), Italy

P. IVA IT07462810966. Copyright © 2026 Empatica Inc. - ISO 13485 Cert. No. 39050072201 - All rights reserved - Legal